Who Owns ARS Pharmaceuticals Stock?
NASDAQ: SPRYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 85.56%
- Institutions (% of float)
- 105.96%
- Held by insiders
- 19.25%
- Institutional holders
- 262
- Institutions 80.7%
- Insiders 19.3%
- Public and other 0.0%
Who owns ARS Pharmaceuticals stock?
Institutional investors own about 85.6% of ARS Pharmaceuticals's shares, spread across 262 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 19.25% of SPRY.
The largest institutional holders are RA Capital Management, L.P. (10.80%), Rubric Capital Management LP (8.50%) and Orbimed Advisors LLC. (8.24%). Together, the top 10 institutions control 57.5% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their SPRY positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SPRY
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 10.86M | 10.80% | 0.0% |
| Rubric Capital Management LP | 8.54M | 8.50% | +6.8% |
| Orbimed Advisors LLC. | 8.29M | 8.24% | 0.0% |
| Deerfield Management Company, L.P | 7.50M | 7.46% | 0.0% |
| Blackrock Inc. | 5.58M | 5.55% | +5.1% |
| SR One Capital Management, LP | 4.01M | 3.99% | 0.0% |
| State Street Corporation | 3.69M | 3.67% | -1.1% |
| UBS Group AG | 3.66M | 3.65% | +89.0% |
| Tyro Capital Management LLC | 3.20M | 3.18% | -28.2% |
| Vanguard Capital Management LLC | 2.50M | 2.49% | -2.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SPRY
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.18M | 2.16% |
| SmallCap World Fund Inc | 1.91M | 1.90% |
| abrdn Healthcare Opportunities Fund | 1.81M | 1.80% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.75M | 1.74% |
| iShares Trust-iShares Russell 2000 ETF | 1.62M | 1.61% |
| abrdn Healthcare Investors | 1.57M | 1.57% |
| General American Investors Company, Inc. | 908.43K | 0.90% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 746.06K | 0.74% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 708.69K | 0.70% |
| abrdn Life Sciences Investors | 651.54K | 0.65% |
Frequently asked questions
Who is the largest shareholder of ARS Pharmaceuticals?
RA Capital Management, L.P. is the largest institutional shareholder of SPRY, owning 10.80% of shares outstanding (10.86M shares) as of its latest 13F filing.
What percentage of ARS Pharmaceuticals is owned by institutions?
Institutions own about 85.6% of SPRY shares and 106.0% of the public float.
How much of ARS Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 19.25% of SPRY shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.